Basic Filitra Information

• INN (International Nonproprietary Name): Vardenafil
• Brand Names Available In United Kingdom: Levitra (film-coated tablets 2.5 mg, 5 mg, 10 mg, 20 mg), Staxyn (oral disintegrating 10 mg), Filitra (appears in some online pharmacies and export markets but is not registered in major UK/EU registries)
• ATC Code: G04BE09
• Forms & Dosages: Tablets 2.5, 5, 10, 20, 40, 60 mg; Orodispersible tablet 10 mg (Staxyn)
• Manufacturers In United Kingdom: Leading vardenafil suppliers for regulated markets include Bayer Plc (Levitra) and distributors such as GlaxoSmithKline for UK distribution; Filitra manufacturers commonly listed in export channels include Fortune Health Care (India) and Centurion Remedies (India)
• Registration Status In United Kingdom: Levitra and generics containing vardenafil are authorised in the UK; Filitra is not listed in major authoritative regulatory registries and is not registered in these jurisdictions
• OTC / Rx Classification: Prescription Only (Rx)
• Standard Dosages (Erectile Dysfunction): Recommended initial dose for adult men 10 mg orally taken approximately 60 minutes before sexual activity; may be decreased to 5 mg or increased to a maximum of 20 mg based on efficacy and tolerability; not more than once daily
• Dosage Adjustments: Not indicated for under 18s; elderly—no routine initial adjustment but start at lowest effective dose if frail; renal mild–moderate no adjustment; severe renal impairment use lowest dose with caution; hepatic moderate impairment maximum 10 mg; severe hepatic impairment contraindicated
• Treatment Regimen: On‑demand use only; long‑term safety beyond six months not fully established for all populations
• Storage & Transport: Store at room temperature 20°–25°C; keep in original packaging away from light and moisture
• Absolute Contraindications: Concurrent nitrate therapy; severe hepatic impairment; known hypersensitivity to vardenafil or excipients; severe cardiac disorders where sexual activity is not advised
• Relative Precautions: Conditions predisposing to priapism (sickle cell, leukaemia, multiple myeloma); penile anatomical deformity; severe renal impairment; use with alpha‑blockers or drugs prolonging QT interval
• Common Side Effects: Flushing; headache; nasal congestion/sinus pain; dyspepsia; dizziness; back pain

Latest Research Highlights (UK + EU)

Patients ask whether vardenafil works faster and is as safe as other PDE5 inhibitors.

Recent UK and EU clinical research (2022–2025) continues to show vardenafil as an effective PDE5 inhibitor with a generally favourable safety profile comparable to sildenafil and tadalafil.

Published randomised controlled trials and pooled analyses note a quicker onset of action for vardenafil versus sildenafil, making it useful where a faster onset is desired.

Head‑to‑head data report similar overall efficacy on erectile function measures such as IIEF improvement, though absolute effect sizes and numbers needed to treat (NNT) are not specified in the available summary data.

EU pharmacovigilance has not identified new class‑wide safety warnings unique to vardenafil, but MHRA Yellow Card reports remain the primary source for post‑marketing safety signals in the UK.

Research gaps persist, notably long‑term safety beyond six months and outcomes in special populations (severe hepatic disease, significant cardiac comorbidity, complex polypharmacy).

Practical implication: faster onset may suit sporadic planned encounters, while safety aligns with the PDE5 inhibitor class.

Clinical Effectiveness In The UK

Patients commonly want to know what to expect in NHS practice.

In UK and NHS settings, vardenafil is associated with measurable improvements in erectile function scores and patient‑reported sexual satisfaction when used appropriately for erectile dysfunction.

Prescribing patterns favour licensed brands such as Levitra and orodispersible Staxyn, and generics where available.

Major outcome metrics seen in practice include IIEF score changes, time to satisfactory intercourse, and adherence rates; exact numeric values are not specified in the supplied data.

• IIEF Score Changes: Improvement reported versus baseline (details not specified).
• Time To Satisfactory Intercourse: Often within 60–90 minutes after a 10 mg dose.
• Discontinuation Rates: Often due to side effects, partner factors, or preference for different agents (specific rates not specified).

Common mild adverse events in UK clinics are flushing, headache, nasal congestion, dyspepsia, dizziness and back pain, and these are the usual counselling points.

Community pharmacists at Boots, LloydsPharmacy and Superdrug play an active role in supporting adherence, electronic prescription transfers and patient counselling.

Evidence‑based recommendation: prescribe licensed vardenafil formulations and report adverse drug reactions via the MHRA Yellow Card system.

Indications & Expanded Uses

People often ask whether vardenafil is for anything other than erectile dysfunction.

Licensed Indication

Adult men with erectile dysfunction; on‑demand use only.

Not Indicated

Women and under‑18s — no approved indications or paediatric data.

Regulatory Recognition

MHRA/EMA recognise vardenafil for erectile dysfunction; Filitra is not registered in major regulatory registries.

Off‑label and experimental use is occasionally reported in private practice, for example adjunctive use for lower urinary tract symptoms, but evidence is limited and NHS guidance usually does not recommend such uses.

Contraindications that limit expanded use include concurrent nitrate therapy, severe hepatic impairment and significant cardiac conditions.

Where off‑label prescribing is considered, the medicolegal position requires informed consent and clear documentation in line with GMC guidance.

Private sexual health clinics commonly facilitate shared decision‑making on off‑label options, while community pharmacists should flag non‑registered brands such as Filitra to patients and prescribers.

Composition & Brand Landscape

Patients often ask which brand is "best" and what formulations exist.

The active ingredient is vardenafil (INN).

Levitra (Bayer) is widely authorised in the UK and EU and is usually supplied as orange, round, film‑coated tablets with the "BAYER cross" imprint in strengths up to 20 mg for regulated markets.

Staxyn offers a 10 mg orodispersible option for patients who prefer a dissolving tablet.

Filitra appears commonly in online international e‑pharmacies with variable strengths (10/20/40/60 mg) and manufacturers such as Fortune Health Care or Centurion Remedies, but it is not registered in major UK/EU registries.

Supply chain considerations include parallel imports and counterfeit risk, so pharmacists should source from MHRA‑regulated suppliers and verify batch numbers and licences.

Contraindications & Special Precautions

Safety questions are frequent; here are the absolute and relative restrictions to check at the pharmacy counter.

Absolute Contraindications

• Concurrent nitrate therapy (oral, sublingual, transdermal) — do not prescribe or supply.
• Severe hepatic impairment — contraindicated.
• Known hypersensitivity to vardenafil or any excipient.
• Severe cardiac disorders where sexual activity is not advised.

Relative Precautions

• Conditions predisposing to priapism: sickle cell disease, leukaemia, multiple myeloma.
• Penile anatomical deformity.
• Severe renal impairment — use lowest dose with caution.
• Concomitant alpha‑blocker therapy — increased risk of postural hypotension.
• Drugs that prolong the QT interval and potent CYP3A4 inhibitors.

Dosing limits from regulatory data: in moderate hepatic impairment max 10 mg; severe hepatic impairment is contraindicated.

Elderly patients require consideration — no routine initial adjustment but start at the lowest effective dose in frail patients.

Patient safety actions include counselling to avoid nitrates, warning about driving or excess alcohol that may potentiate hypotension, and urgent care instructions for priapism.

Report suspected adverse reactions via MHRA Yellow Card.

Dosage Guidelines (NHS‑Focused)

Typical patient question: "How should I take it and what dose do I start on?"

Recommended initial adult dose is 10 mg orally about 60 minutes before sexual activity.

Titrate to 5 mg if poorly tolerated or increase to a maximum of 20 mg if response is inadequate.

Do not take more than one dose in 24 hours.

On‑demand scheduling only; daily fixed dosing is not the standard NHS regimen.

Pharmacist counselling prompts include checking for nitrates, potent CYP3A4 inhibitors and relevant cardiac history before supply.

Note: Filitra is variably sold in unregulated strengths up to 60 mg online, which is outside MHRA/NHS formularies.

Interactions Overview

Drug interactions are a frequent source of serious harm — check these before supply.

Pharmacists should reconcile medication lists, check electronic prescribing interaction flags, and counsel patients on avoiding nitrates and staggering alpha‑blockers where advised.

Be alert to patients buying Filitra from unregulated sources as composition and interaction risk may be unpredictable.

Cultural Perceptions & Patient Habits In The UK

Many men feel embarrassment about seeking help for erectile dysfunction and prefer discreet options.

• Reluctance To Discuss With GPs: Some patients avoid GP consultations and look to online services for convenience and privacy.
• Pharmacist Confidentiality Valued: Community pharmacists are commonly trusted for confidential advice at Boots, LloydsPharmacy and Superdrug.
• Growth In Online Consultations: Telehealth and e‑pharmacies have increased access, but carry risks around unregistered products.
• Regional Variation: Help‑seeking behaviour varies across regions and clinics.

Risk behaviour includes purchasing Filitra online to avoid GP visits, exposing patients to unregistered or counterfeit products.

UK culture tends to favour privacy and convenience, which explains interest in e‑prescriptions and private telehealth services.

Clinicians and pharmacists should use patient‑centred language, signpost NHS resources and sexual health clinics, and emphasise safe sourcing of licensed medicines.

Availability & Pricing Patterns (UK Regions)

Access depends on NHS prescription rules, private prescriptions and online pharmacy offerings.

• NHS Prescriptions: England charges per item (check current NHS rates); Scotland, Wales and Northern Ireland generally provide free prescriptions.
• Private Prescriptions: Used for faster access or by those preferring private consultations.
• Online Pharmacies: Licensed chains accept NHS electronic prescriptions; independent e‑pharmacies vary in accreditation.

Levitra and generics are authorised and commonly stocked by Boots, LloydsPharmacy and Superdrug across the UK.

Filitra is typically not registered in the UK and is mainly found via international e‑pharmacies and parallel imports.

Regional cost differences matter: patients in Scotland, Wales and Northern Ireland often avoid per‑item charges, while patients in England may choose between NHS supply and private purchase based on cost and speed.

In our online pharmacy, filitra is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.

Always verify MHRA registration and credentials of online sellers to reduce counterfeit risk.

Comparable Medicines And Prescribing Preferences

Patients ask which PDE5 inhibitor best fits their lifestyle and health profile.

NHS prescribing choices balance formulary availability, cost‑effectiveness and patient lifestyle (planned vs spontaneous encounters).

Clinicians and pharmacists should consider onset, duration, interaction profile and tolerability when switching between agents.

Always prefer licensed products such as Levitra, Staxyn or authorised generics rather than unregulated Filitra variants.

FAQ

1. Can I Buy Filitra Over The Counter?

   No. Vardenafil is prescription‑only in the UK and licensed brands such as Levitra or Staxyn are used in NHS and private practice.

   Filitra is often unregistered in major UK/EU registries and buying it over the counter from unregulated sites carries health risks.

2. How Quickly Does Vardenafil Work And How Often Can I Take It?

   Typical onset is around 60 minutes after a 10 mg dose and it should not be taken more than once daily.

   Dosing can be adjusted to 5–20 mg based on tolerability and effect.

3. Are There Serious Risks?

   Yes. Concurrent use with nitrates is an absolute contraindication and severe hepatic impairment is contraindicated.

   Seek urgent care for prolonged erections (priapism) or signs of severe hypotension or vision changes.

4. Where Should I Get It?

   Obtain vardenafil via an NHS prescription, a trusted private clinic, or MHRA‑regulated pharmacies such as Boots, LloydsPharmacy or Superdrug.

   Report suspected adverse reactions via the MHRA Yellow Card and seek NHS 111 or sexual health services for concerns.

Common side effects to expect include flushing, headache, nasal congestion, dyspepsia, dizziness and back pain.

Guidelines For Proper Use & Pharmacist Counselling

Pharmacists need a concise script and checklist for safe and effective supply.

• Confirm prescription source and MHRA registration of the product.
• Review concurrent nitrates, cardiovascular history and other medications (notably CYP3A4 inhibitors and alpha‑blockers).
• Check liver and renal status; note that moderate hepatic impairment limits dose to 10 mg and severe hepatic impairment is contraindicated.
• Advise dosing: start 10 mg approximately 60 minutes before activity; titrate to 5–20 mg as required; not more than once daily.
• Explain common side effects and the emergency response for priapism.
• Storage advice: store at room temperature 20°–25°C in original pack away from light and moisture.
• Document private prescriptions and obtain informed consent for any off‑label use per GMC guidance.
• Flag unregulated Filitra purchases and recommend licensed alternatives such as Levitra or Staxyn.

Suggested brief script: “This medicine contains vardenafil; take one 10 mg tablet about an hour before sex; don’t mix with nitrates; if you have chest pain or a prolonged erection over four hours seek emergency care; I’ll arrange a follow‑up or you can return if side effects occur.”

Signpost patients to NHS portals, sexual health clinics and the MHRA Yellow Card for reporting adverse reactions.

Delivery Across United Kingdom